| Source: Market Study Report Market Study Report
Pune, India, Oct. 12, 2022 (GLOBE NEWSWIRE) — MarketStudyReport recently added latest report, global diabetes management devices market size is likely to record an 8.4% CAGR during 2022-2028. The rising incidence of diabetes among the younger & older population, surging cases of obesity prompted by increasing intake of junk food & alcohol, the continuous R&D activities in the healthcare sector, and the introduction of innovative devices are some of the primary factors driving the growth of global diabetes management devices market.
Alongside a detailed evaluation of the key regions, namely Latin America, North America, Western Europe, Eastern Europe, and Asia Pacific. The research literature unveils the top opportunities across these geographies. Besides, in-depth segmentation studies, including device type, distribution channel, and end-users are provided for a broad view of the industry. Proceeding further, the study presents a 360-degree view of the leading industry players with respect to their financials, product/service portfolio, and major developments like mergers, partnerships, and investments.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/5587037/

Moreover, the rising prevalence of Type I and Type II diabetes in the geriatric population coupled with the soaring demand for devices like insulin pens and pumps are some of the essential factors propelling the overall industry development.
Market segments overview:
Worldwide diabetes management devices market is segmented on the basis of device type, end-user, and distribution channel.
Based on device type, the industry is bifurcated into insulin delivery devices and blood glucose monitoring devices. Further, blood glucose monitoring device is divided into continuous glucose monitoring devices (insulin pens, insulin syringes, insulin pumps, and others), and self-monitoring devices.
Moving on to the distribution channel, the market is segmented into e-commerce websites, diabetes centers/ clinics, hospital pharmacies, and retail pharmacies.
With respect to the end-user terrain, the industry is segmented into hospitals, homecare, and diagnostics centers.
Request Discount of this report @ https://www.marketstudyreport.com/check-for-discount/5587037/
Regional scope:
The regional analysis of this business space extends to Middle East & Africa (South Africa, GCC, and Turkey), Latin America (Brazil, Mexico), Asia-Pacific (Australia, South Korea, India, China, Japan, ASEAN {Indonesia, Vietnam, Malaysia, etc.}), Europe (Germany, UK, France, Spain, Italy, Nordic, Benelux, Poland, Russia), and North America (US, Canada).
Competitive dashboard:
The competitive landscape of global diabetes management devices industry is defined by companies such as Ypsomed Holding AG, Eli Lilly and Company, Rossmax International Ltd., B. Braun Melsungen AG, LifeScan Inc., Sanofi S.A., Insulet Corporation, Bayer AG, Novo Nordisk A/S, Johnson & Johnson, Abbott Laboratories Inc., F. Hoffmann-La Roche AG, and Medtronic plc.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
Global Diabetes Management Devices Market, By Device Type (Revenue, USD Million, 2019-2028)
Global Diabetes Management Devices Market, By Distribution Channel (Revenue, USD Million, 2019-2028)
Global Diabetes Management Devices Market, By End-User Terrain (Revenue, USD Million, 2019-2028)
Global Diabetes Management Devices Market, Regional Rundown (Revenue, USD Million, 2019-2028)
North America
Latin America
Asia Pacific
Western Europe
Eastern Europe
Middle East & Africa
Global Diabetes Management Devices Market, Competitive Sphere (Revenue, USD Million, 2019-2028)
Table of Content:
1. Market Introduction
1.1.         Scope of Study
1.2.         Problem Statement
1.3.         Market Segmentation
2. Assumptions and Acronyms
3. Executive Summary
3.1.         Global Market in 2022
3.2.         Analyst Insights & Recommendations
3.3.         Growth Opportunities and Key Strategies
3.4.         Supply-side and Demand-side Trends
4. Research Methodology
5. Analysis of COVID-19 Impact and Road Ahead
5.1.         Impact on Growth Strategies
5.2.         Impact on Operations and Supply Chain
5.3.         Impact on Product Roll-outs Plans
6. Market Indicators and Background
6.1.         Macro-Economic Factors
6.1.1.      Global Population Overview and Forecast
6.1.2.      Rising Prevalence of Diabetes
6.1.3.      Increasing Incidences of Obesity
6.1.4.      Increasing Geriatric Population
6.1.5.      Healthcare Expenditure by Selected Countries/Region
6.2.         Forecasting Factors
Robust assessment of various factors including industrial performance, industry players’ expenditures, and economic conditions, among others
6.3.         Supply Chain & Value Chain Analysis
6.3.1.      Raw Material Suppliers
6.3.2.      Diabetes Management Devices Manufacturers
6.3.3.      Key End Users
6.3.4.      Marketing Channel   Direct Marketing   Indirect Marketing   Marketing Channel Development Trend
6.4.         Industry SWOT Analysis
6.5.         PESTLE Analysis
6.6.         Porter’s Five Forces Analysis
7. Government Laws and Industry Regulations
8. Global and Regional Market Dynamics
8.1.         Drivers
8.2.         Restraints
8.3.         Trends
8.4.         Opportunities
9. Global Diabetes Management Devices Market: Key Investment Analysis
9.1.         By Manufacturers
9.2.         By Region
9.3.         M&A Activities
Robust assessment of major investments made by various industry players along with key application areas, technological assessment, and key end-use sector
10. Pricing Analysis
10.1.       By Leading Organizations
10.2.       By Type
10.3.       By Region
10.3.1.    North America
10.3.2.    Western Europe
10.3.3.    Eastern Europe
10.3.4.    Asia Pacific
10.3.5.    Latin America
10.3.6.    Middle East & Africa
11. Parent Market Overview: Global Medical Devices Market
12. Segmental Analysis
13. Regional Analysis
Related Report:
Global Diabetes Monitoring Devices Market 2022-2028
The global diabetes monitoring devices market is anticipated to increase by USD 9 billion till 2028 at an average annual growth of 5.9 percent as per the latest report. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global diabetes monitoring devices market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the diabetes monitoring devices industry. Based on region, the diabetes monitoring devices market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW). North America is estimated to account for the largest share of the global diabetes monitoring devices market.
About US:
Market Study Report is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, is the platform that can help you in achieving any of these objectives.


By admin

Leave a Reply

Your email address will not be published. Required fields are marked *